# Cancer Prevention and Control Program - 05

> **NIH NIH P30** · JOHNS HOPKINS UNIVERSITY · 2021 · $36,923

## Abstract

ABSTRACT
Effective cancer prevention and control requires a better understanding of the causes and risk factors for
cancer as well as the development and testing of strategies to prevent cancer and improve the quality of
cancer care. The mission of the Cancer Prevention and Control (CPC) Program of the Sidney Kimmel
Comprehensive Cancer Center (SKCCC) is to conduct population-focused, multidisciplinary and translational
cancer research, with the goal of developing preventive measures. These include early detection approaches
and interventions needed to reduce cancer incidence, recurrence/progression and related deaths as well as
improving health-related quality of life and care of cancer patients. Program research is organized around three
research themes with the following aims:
Aim 1: Cancer Epidemiology: To identify causes of cancer occurrence in at-risk populations and poor objective
outcomes in cancer patients using epidemiologic methods.
Aim 2: Viral Oncology: To understand the role of viruses in cancer, specifically human papillomavirus (HPV),
human herpesvirus-8 (HHV-8), human T-lymphotropic virus 1 (HTLV-1) and hepatitis B virus (HBV), and the
mechanisms and biomarkers of this oncogenesis as the basis for developing preventive, diagnostic and
therapeutic strategies.
Aim 3: Patient-Centered Outcomes and Palliative Care Research: To assess and determine how to improve
patient-reported outcomes and the quality of care services, including palliative care.
The CPC Program's portfolio of research addresses the causes of cancer and spans the cancer control
continuum, from prevention to survivorship and end of life. The Program facilitates Intra- and Inter-
Programmatic population-based, translationally focused research on cancer, including team science. It recruits
and mentors new investigators whose research is compatible with its mission; coordinates seminars and other
venues for information exchange on cutting-edge, population-focused research and methods; participates in
state and local public health efforts to translate knowledge learned into improved practice; and generates
knowledge informing cancer care across the cancer control continuum in the health system, the catchment
area, nationally and globally. The Program benefits from the Maryland Cigarette Restitution Fund (CRF) at
Johns Hopkins (2001–present) through support for new faculty recruitments and population-focused
translational research pilot projects. The SKCCC, and particularly the CPC Program, is fully engaged in the
Maryland state government's comprehensive cancer control planning and implementation and the Maryland
State Council on Cancer Control. The CPC Program includes 36 members from 14 departments and three
schools, and two members-in-development. NCI and other peer-reviewed support of Program members totals
$18.4 million total costs. Program members have 707 publications—101 (14%) are Intra-Programmatic, 291
(41%) are Inter-Programmatic and 355 (50%) publications rep...

## Key facts

- **NIH application ID:** 10135911
- **Project number:** 5P30CA006973-58
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** Richard Bruce Roden
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $36,923
- **Award type:** 5
- **Project period:** 1997-05-07 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10135911

## Citation

> US National Institutes of Health, RePORTER application 10135911, Cancer Prevention and Control Program - 05 (5P30CA006973-58). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10135911. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*